Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600851.SS Gross Margin

The Gross Margin of Shanghai Haixin Group Co Ltd (600851.SS) is 46.37%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

600851.SS Gross Margin - Historical Value
Date Value
2025-12-31 46.37%
2024-12-31 53.14%
2023-12-31 46.37%
600851.SS Gross Margin - Peers Comparison
Ticker Name Value
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 72.71%
605116.SS Aurisco Pharmaceutical Co Ltd 58.92%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd 27.16%
300006.SZ Chongqing Lummy Pharmaceutical Co Ltd 54.68%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 53.90%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd 16.11%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 38.22%
603222.SS Chimin Health Management Co Ltd 24.10%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 61.25%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 55.25%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 26.63%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 75.14%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 57.21%
000915.SZ Shandong WIT Dyne Health Co Ltd 84.66%
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 75.14%
002550.SZ Changzhou Qianhong Biopharma Co Ltd 58.02%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.92%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 68.88%
300110.SZ Huaren Pharmaceutical Co Ltd 34.59%
603669.SS Lionco Pharmaceutical Group Co Ltd 42.75%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 69.41%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 32.69%
603566.SS Pulike Biological Engineering Inc 59.80%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 74.92%
300199.SZ Hybio Pharmaceutical Co Ltd 56.41%
300723.SZ ApicHope Pharmaceutical Group Co Ltd 55.39%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 80.67%
600624.SS Shanghai Fudan Forward S&T Co Ltd 13.35%